Sign In
Buy BIO
$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
08:00am, Thursday, 18'th Jun 2026
Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate Pharmaceutical Manufacturing AGOURA HILLS, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Oncotelic Ther
BIO-key's Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur.
07:59am, Thursday, 18'th Jun 2026
Biometric authentication provider BIO-key's (BKYI) CEO will participate in a webcast fireside chat at Maxim Group's Defense Tech Conf. 6-25 at 4pm, track 2
BioHarvest Sciences to Present at the 2026 BIO International Convention
07:30am, Thursday, 18'th Jun 2026
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
07:00am, Wednesday, 17'th Jun 2026
Company to Conduct Partnering Meetings Focused on Oncology, Liver Disease and Inflammatory Disease RAMAT GAN, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (T
Silexion Therapeutics to Attend BIO International Convention 2026
04:30pm, Tuesday, 16'th Jun 2026
Grand Cayman, June 16, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies f
Enveric Biosciences Announces Participation in 2026 BIO International Convention
09:28am, Tuesday, 16'th Jun 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to addr
Neurophet Showcases 'Brain Imaging AI Solutions' at BIO USA, Accelerates Global Business Development Collaborations
09:00am, Tuesday, 16'th Jun 2026
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-making Expands partnering efforts with global pharmaceutical and biotech comp
BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing
05:00pm, Wednesday, 10'th Jun 2026
HOLMDEL, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, a
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN.
04:10pm, Thursday, 04'th Jun 2026
KUALA LUMPUR, MALAYSIA, June 04, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; the “Company”) today announced that it entered into a Business Combination Agreement (“BCA�
BIO-key's RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ET
07:58am, Thursday, 04'th Jun 2026
BIO-key's RedChip Future Tech Investor Conference Presentation to Webcast Wed. June 10 at 3pm ET URL: https://www.redchip.com/webinar/redchip/89763628854.
Bio-Rad Laboratories, Inc. (BIO) Presents at Jefferies Global Healthcare Conference 2026 Transcript
12:41pm, Wednesday, 03'rd Jun 2026
Bio-Rad Laboratories, Inc. (BIO) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Lexaria Attending the BIO International Convention, as part of a Broader Business Development Program
09:25am, Wednesday, 03'rd Jun 2026
Kelowna, British Columbia - June 3 , 2026 – TheNewswire - Lexaria Bioscience Corp. (NASDAQ: LEXX) (“Lexaria” or the “Company”), a global innovator in oral drug delivery platforms , announces
Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event
09:00am, Wednesday, 03'rd Jun 2026
Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), targets $2 billion peak annual revenue potential 12-LOX cou
UPDATE: BIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit Union
12:48pm, Tuesday, 02'nd Jun 2026
BIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit Union via Strategic IT Solutions Partnership with Provider BlueAlly
BIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit UnionBynum, AL
07:59am, Tuesday, 02'nd Jun 2026
BIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit Union via Strategic IT Solutions Partnership with Provider BlueAlly
